
Alcon has received European CE mark for a trifocal IOL (AcrySof IQ PanOptix) designed for patients who are undergoing cataract surgery and want to address their near, intermediate, and distance vision needs with one lens.

Alcon has received European CE mark for a trifocal IOL (AcrySof IQ PanOptix) designed for patients who are undergoing cataract surgery and want to address their near, intermediate, and distance vision needs with one lens.

Anti-vascular endothelial growth factor (anto-VEGF) monotherapy is inadequate in patients with age-related macular degeneration (AMD). However, by adding an anti-platelet-derived growth factor (anti-PDGF) drug to the anti-VEGF regimen, treatment is enhanced by preventing the development of fibrosis thus improving visual outcomes, according to Usha Chakravarthy, MBBS, PhD.

It has been established that implementing electronic health records (EHR) has not been well received by physicians. Complaints of EHR costs and complications are among a laundry list of concerns physicians have voiced since the system’s mandated adoption. Ophthalmology Times asked three EHR experts to list the most common complaints they have heard physicians experience while addressing the implementation, and their advice on solving these issues.

In her latest blog, Donna Suter, gives advice on adding an extra profit boost to your clinic.

A smartphone lens adapter and app that allows users to conduct extensive eye exams on patients is as accurate as traditional charts, according to a recent study.

A laser tissue bonding apparatus integrated with an optical coherence tomography (OCT) probe is a plausible instrument that allows for temperature-controlled laser bonding of incisions in the cornea, according to Israeli researchers. The OCT probe can provide real-time feedback of structural change of the corneal tissue, and indicate the progress and end point of the bonding.

A team of researchers from Denmark believes it has found a way for ophthalmologists to identify the patients who will most likely to benefit from age-related cataract surgery.

Mark Packer, MD, explains what he wish he knew in med school.

Recent developments imply it may be time to change the current view of amblyopia. Laboratory findings show that the adult cortex is more adaptable than previously thought and that amblyopia may be secondary to binocular problems.

In cases of an inverted Brown pattern, a large inferior oblique weakening procedure may be the first procedure to perform-even though the inferior oblique muscle is not significantly overacting.

Among the trends from a membership survey conducted by the American Academy of Ophthalmology are an increase in part-time practice and greater diversity. However, many share similar concerns about upheavals in health care.

Though both ink marking and a newly introduced digital markerless system for toric IOL correction are effective, the digital system improved predictability and eliminated outliers in a comparison study.

Glaucoma specialists and general ophthalmologists alike must be aware of some significant procedure coding changes that will increase the complexity of the glaucoma surgical code set.

No doubt, my retina colleagues are way ahead of me in considering this issue. Reducing the frequency of injections by developing longer-lasting therapeutic agents and reducing the per-injection risk by careful scrutiny of evidence to determine the best practice when it comes to injection protocols are two possibilities.

Today’s laser cataract surgery is outperforming the early days of phacoemulsification and may outperform current phacoemulsification technology in the next few years, explained Yassine Daoud, MD, in a dialogue about the technology.

Cataract surgery lowers IOP in eyes with exfoliation syndrome (XFS) or exfoliation glaucoma (XFG), and it might even change the natural history of glaucoma in eyes with XFS. However, it may also be appropriate to combine phacoemulsification with glaucoma surgery in certain patients with XFG.

Toric IOL implantation using a proprietary image-guided system for planning and executing cataract surgery results in good accuracy to cylinder and MRSE targets.

Rho kinase inhibitors are intriguing in that they work directly on the pathogenic mechanism of abnormally elevated IOP, increased resistance to trabecular outflow.

A calcium channel blocker may be associated with marginal pupil dilation, making it more likely that pupil-dilating devices will be needed during phacoemulsification.

A new phacoemulsification system offers surgical functionality, features, and technology in a compact form factor.

One-year outcomes with a subretinal implant for patients blinded by retinitis pigmentosa demonstrated a marked improvement in visual capabilities.

Dropless cataract surgery-a combination of anti-infective and anti-inflammatory drugs injected transzonularly or through the pars plana for deposit into the vitreous-reduces the need for topical postoperative drops.

The Laser Cataract Consortium, comprising five experienced laser cataract surgeons, undertook a study incorporating rigorous collection of data from 7,200 eyes undergoing cataract surgery.

The eyewear market is changing more rapidly than ever, and it is no longer acceptable to sell the same way to each consumer. Staying up-to-date on how to leverage unique marketing to every generation is the key to success.

In her latest blog, Joy Gibb, ABOC, solves the much avoided topic of handling your most stubborn patients.

Did your state make the list?

One surgeon’s experiences with the iStent trabecular micro bypass; an implant that forms a patent opening through the trabecular meshwork into Schlemm’s canal, restoring physiological aqueous outflow and providing a significant and sustained decrease in IOP.

Bleb failure can often be avoided with well-managed trabeculectomy and effective postoperative care.

In this article, Dr Johannson presents intraindividual IOL comparison follow-up results. Although similar levels of PCO development were observed for both AcrySof and Tecnis one-piece IOLs, fewer glistenings appeared in the Tecnis material, 3 years after implantation.

A protein called PKal (plasma kallikrein) and its associated molecules are key players in an inflammatory molecular pathway involved in diabetic macular edema, according to a study published in Diabetes.